Environmental Mycotoxin Panel from RealTime Laboratories

The current price is clearly stated at $319 and general shipping, refund, and kit-validity terms are available. Free continental United States shipping above $100 is favorable, but a roughly $50 deduction, pre-specimen timing requirement, six-month validity window, and final-sale language create material buyer tradeoffs.

The current offer states coverage of 16 mycotoxins, including 9 macrocyclic trichothecenes, which is a defined scope for an environmental toxin screen. Coverage is bounded because the complete current analyte list is absent, the method document names 15 analytes, and species identification and quantity are handled by a separate Fungal Count Dx product.

The panel's environmental specimen and stated home or workplace use directly match a question about whether listed mycotoxins are present in a building sample. The provider's informational and healthcare-review language helps bound the use, but the public evidence does not show how a positive environmental result maps to a person's exposure, illness, or remediation decision.

The product page links a report and the provider states that results are informational and should be reviewed with a qualified healthcare provider. The current official-domain sample-report asset returned 404, so the actual report presentation, reference or threshold labels, quality handling, uncertainty, and environmental action guidance could not be verified.

The official method document provides meaningful assay evidence, including ELISA method context, accuracy and precision targets, linearity, detection limits, specificity, and CAP and CLIA statements. The document combines broader EMMA content, states 15 mycotoxins rather than the current page's 16, and does not fully tie the performance data to the current filter-dust product version.

Ordering and collection are practical on the face of the current offer: a buyer can purchase the kit, collect environmental material at home, use the listed return sleeve, and receive a product-specific result statement within 10 days. General shipping and support are documented, but state eligibility and current provider or inspector availability remain unresolved.

The provider publishes a general privacy page with access and deletion language and terms that address confidentiality, security limits, and lawful result use. It does not publish the product-specific health-data lifecycle, environmental specimen handling, research or sharing practice, sample destruction schedule, or result-retention period needed for a stronger privacy assessment.

The page discloses the product label, price, environmental specimen route, stated marker count, kit contents, turnaround, and general laboratory and refund information. Evaluation remains incomplete because the current analyte list, exact current collection protocol, current sample report, state availability, and product-specific privacy or retention terms are not fully public.